 |
 |

Effect of Raw Garlic vs Commercial Garlic Supplements on Plasma Lipid Concentrations in Adults With Moderate HypercholesterolemiaA Randomized Clinical Trial
Christopher D. Gardner, PhD;
Larry D. Lawson, PhD;
Eric Block, PhD;
Lorraine M. Chatterjee, MS;
Alexandre Kiazand, MD;
Raymond R. Balise, PhD;
Helena C. Kraemer, PhD
Arch Intern Med. 2007;167(4):346-353.
Background Garlic is widely promoted as a cholesterol-lowering agent, but efficacy studies have produced conflicting results. Garlic supplements differ in bioavailability of key phytochemicals. We evaluated the effect of raw garlic and 2 commonly used garlic supplements on cholesterol concentrations in adults with moderate hypercholesterolemia.
Methods In this parallel-design trial, 192 adults with low-density lipoprotein cholesterol (LDL-C) concentrations of 130 to 190 mg/dL (3.36-4.91 mmol/L) were randomly assigned to 1 of the following 4 treatment arms: raw garlic, powdered garlic supplement, aged garlic extract supplement, or placebo. Garlic product doses equivalent to an average-sized garlic clove were consumed 6 d/wk for 6 months. The primary study outcome was LDL-C concentration. Fasting plasma lipid concentrations were assessed monthly. Extensive chemical characterization of study materials was conducted throughout the trial.
Results Retention was 87% to 90% in all 4 treatment arms, and chemical stability of study materials was high throughout the trial. There were no statistically significant effects of the 3 forms of garlic on LDL-C concentrations. The 6-month mean (SD) changes in LDL-C concentrations were +0.4 (19.3) mg/dL (+0.01 [0.50] mmol/L), +3.2 (17.2) mg/dL (+0.08 [0.44] mmol/L), +0.2 (17.8) mg/dL (+0.005 [0.46] mmol/L), and –3.9 (16.5) mg/dL (–0.10 [0.43] mmol/L) for raw garlic, powdered supplement, aged extract supplement, and placebo, respectively. There were no statistically significant effects on high-density lipoprotein cholesterol, triglyceride levels, or total cholesterol–high-density lipoprotein cholesterol ratio.
Conclusions None of the forms of garlic used in this study, including raw garlic, when given at an approximate dose of a 4-g clove per day, 6 d/wk for 6 months, had statistically or clinically significant effects on LDL-C or other plasma lipid concentrations in adults with moderate hypercholesterolemia.
Clinical Trial Registry http://clinicaltrials.gov Identifier: NCT00056511
Author Affiliations: Stanford Prevention Research Center and Department of Medicine, Stanford University Medical School, Stanford, Calif (Drs Gardner, Kiazand, Balise, and Kraemer and Ms Chatterjee); Plant Bioactives Research Institute, Orem, Utah (Dr Lawson); and Department of Chemistry, University at Albany, State University of New York (Dr Block).
CiteULike Connotea Delicious Digg Facebook Reddit Technorati Twitter
What's this?
RELATED LETTERS
Effects of Garlic on Cholesterol: Not Down But Not Out Either
David Maslin
Arch Intern Med. 2008;168(1):111-112.
EXTRACT
| FULL TEXT
Effects of Garlic on Cholesterol: Not Down But Not Out Either—Reply
Christopher Gardner, Larry D. Lawson, and Eric Block
Arch Intern Med. 2008;168(1):112-113.
EXTRACT
| FULL TEXT
RELATED ARTICLE
Garlic: What We Know and What We Don't Know
Mary Charlson and Marcus McFerren
Arch Intern Med. 2007;167(4):325-326.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Use of Herbal Products and Potential Interactions in Patients With Cardiovascular Diseases
Tachjian et al.
J Am Coll Cardiol 2010;55:515-525.
ABSTRACT
| FULL TEXT
Effects of Garlic on Cholesterol: Not Down But Not Out Either Reply
Gardner et al.
Arch Intern Med 2008;168:112-113.
FULL TEXT
Effects of Garlic on Cholesterol: Not Down But Not Out Either
Maslin
Arch Intern Med 2008;168:111-112.
FULL TEXT
The Year in Epidemiology, Health Services Research, and Outcomes Research
Krumholz and Masoudi
J Am Coll Cardiol 2007;50:2254-2262.
FULL TEXT
Garlic Strikes Out for Lipid Lowering
Journal Watch Cardiology 2007;2007:3-3.
FULL TEXT
Garlic Consumption and Cholesterol
JWatch General 2007;2007:7-7.
FULL TEXT
Garlic: What We Know and What We Don't Know
Charlson and McFerren
Arch Intern Med 2007;167:325-326.
FULL TEXT
|